Cargando…

Efficacy of Surfactant-TA, Calfactant and Poractant Alfa for Preterm Infants with Respiratory Distress Syndrome: A Retrospective Study

PURPOSE: To compare the efficacy of the new drug calfactant with the commonly used drugs surfactant-TA and poractant alfa. MATERIALS AND METHODS: A total of 332 preterm infants at 24-31 weeks' gestation with respiratory distress syndrome (RDS) were enrolled and allocated to three groups accordi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeon, Ga Won, Oh, Minkyung, Sin, Jong Beom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329355/ https://www.ncbi.nlm.nih.gov/pubmed/25683992 http://dx.doi.org/10.3349/ymj.2015.56.2.433

Ejemplares similares

Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study
por: Ramanathan, R, et al.
Publicado: (2013)

The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
por: Pezzi, Mario, et al.
Publicado: (2020)

Nebulized Poractant Alfa Reduces the Risk of Respiratory Failure at 72 Hours in Spontaneously Breathing Surfactant-Deficient Newborn Piglets
por: Rey-Santano, Carmen, et al.
Publicado: (2020)

In Vivo Evaluation of the Acute Pulmonary Response to Poractant Alfa and Bovactant Treatments in Lung-Lavaged Adult Rabbits and in Preterm Lambs with Respiratory Distress Syndrome
por: Ricci, Francesca, et al.
Publicado: (2017)

Surfactant preparations for preterm infants with respiratory distress syndrome: past, present, and future
por: Jeon, Ga Won
Publicado: (2019)

In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits
por: Guo, Xiaojing, et al.
Publicado: (2020)

Poractant alfa versus bovine lipid extract surfactant for infants 24+0 to 31+6 weeks gestational age: A randomized controlled trial
por: Lemyre, Brigitte, et al.
Publicado: (2017)

Poractant alfa (Curosurf(®)) increases phagocytosis of apoptotic neutrophils by alveolar macrophages in vivo
por: Willems, Coen HMP, et al.
Publicado: (2012)

Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials
por: Sánchez Luna, Manuel, et al.
Publicado: (2020)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome
por: Jardine, Luke, et al.
Publicado: (2022)

Early Surfactant Therapy for Respiratory Distress Syndrome in Very Preterm Infants
por: Cucerea, Manuela, et al.
Publicado: (2023)

Dose Effect of Poractant Alfa in Neonatal RDS: Analysis of Combined Data from Three Prospective Studies
por: Królak-Olejnik, Barbara, et al.
Publicado: (2020)

Practical considerations when administering surfactants to preterm infants with respiratory distress syndrome
por: Jo, Heui Seung
Publicado: (2019)

Profound Effect of Pulmonary Surfactant on the Treatment of Preterm Infants with Respiratory Distress Syndrome
por: Liu, Lin, et al.
Publicado: (2022)

Alternative Methods of Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome: State of the Art
por: Erdeve, Ömer, et al.
Publicado: (2021)

Effects of bovine lipid extract surfactant administration in preterm infants treated for respiratory distress syndrome
por: Stockley, Elizabeth, et al.
Publicado: (2018)

Surfactant replacement therapy for respiratory distress syndrome in preterm infants: United Kingdom national consensus
por: Banerjee, Sujoy, et al.
Publicado: (2019)

Thyroid dysfunction in very low birth weight preterm infants
por: Lee, Ji Hoon, et al.
Publicado: (2015)

Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS
por: Ramanathan, R
Publicado: (2006)

Effect of surfactant dose on outcomes in preterm infants with respiratory distress syndrome: the OPTI-SURF study protocol
por: Goss, Kevin Colin William, et al.
Publicado: (2020)

Definitions of bronchopulmonary dysplasia and long-term outcomes of extremely preterm infants in Korean Neonatal Network
por: Jeon, Ga Won, et al.
Publicado: (2021)

Single Nucleotide Polymorphisms Interactions of the Surfactant Protein Genes Associated With Respiratory Distress Syndrome Susceptibility in Preterm Infants
por: Amatya, Shaili, et al.
Publicado: (2021)

The Influence of the Technique of Surfactant Administration (LISA vs INSURE) on the Outcomes of Respiratory Distress Syndrome Treatment in Preterm Infants
por: Kaniewska, Urszula, et al.
Publicado: (2019)

Comparative efficacy of pulmonary surfactant in respiratory distress syndrome in preterm infants: a Bayesian network meta-analysis
por: Qiu, Caihong, et al.
Publicado: (2020)

Comparison of minimally invasive surfactant therapy with intubation surfactant administration and extubation for treating preterm infants with respiratory distress syndrome: a randomized clinical trial
por: Sabzehei, Mohammad Kazem, et al.
Publicado: (2021)

Early Immunomodulatory Effects of Different Natural Surfactant Preparations in Preterms With Respiratory Distress
por: Yalaz, Mehmet, et al.
Publicado: (2022)

Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: Feasibility and outcome
por: Mohammadizadeh, Majid, et al.
Publicado: (2015)

Corrigendum: Single nucleotide polymorphisms interactions of the surfactant protein genes associated with respiratory distress syndrome susceptibility in preterm infants
por: Amatya, Shaili, et al.
Publicado: (2022)

Comparison of definitions of bronchopulmonary dysplasia to reflect the long-term outcomes of extremely preterm infants
por: Jeon, Ga Won, et al.
Publicado: (2022)

Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants
por: Koh, Ji Won, et al.
Publicado: (2018)

FiO(2) Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome
por: Kruczek, Piotr, et al.
Publicado: (2021)

Respiratory support with heated humidified high flow nasal cannula in preterm infants
por: Jeon, Ga Won
Publicado: (2016)

Analysis of the cost-effectiveness of surfactant treatment (Curosurf®) in respiratory distress syndrome therapy in preterm infants: early treatment compared to late treatment
por: Dani, Carlo, et al.
Publicado: (2014)

A multicentre neonatal interventional randomised controlled trial of nebulized surfactant for preterm infants with respiratory distress: Neo-INSPIRe trial protocol
por: Lategan, Ilse, et al.
Publicado: (2023)

Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future
por: Amigoni, Angela, et al.
Publicado: (2017)

Risk Factors of Transfusion in Anemia of Very Low Birth Weight Infants
por: Jeon, Ga Won, et al.
Publicado: (2013)

The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012)

Assessment of hemodynamic changes in preterm infants with respiratory distress syndrome
por: Özdemir, Senem Alkan, et al.
Publicado: (2017)

Bronchoscopic interventions with surfactant and recombinant human deoxyribonuclease for acute respiratory distress syndrome–type respiratory syncytial virus–pneumonia in moderately preterm infants: Case series
por: Krause, Martin F, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gkthpvn34ujkif9kjdplh2gu2q